Immune checkpoint inhibitors in large cell neuroendocrine carcinoma: current status

INTRODUCTION: Large cell neuroendocrine carcinomas (LCNEC) are a group of rare high grade neuroendocrine tumors that often behave clinically like small cell carcinoma (SCLC) and are treated as such. No major advancement in the management of these tumors has occurred in the last 30 years. METHODS: We...

Descripción completa

Detalles Bibliográficos
Autores principales: Chauhan, Aman, Arnold, Susanne M., Kolesar, Jill, Thomas, Hala Elnakat, Evers, Mark, Anthony, Lowell
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2018
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5865703/
https://www.ncbi.nlm.nih.gov/pubmed/29581877
http://dx.doi.org/10.18632/oncotarget.24553

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5865703/
https://www.ncbi.nlm.nih.gov/pubmed/29581877
http://dx.doi.org/10.18632/oncotarget.24553

Ejemplares similares